Holders over time
- EROC
- TMO
| Quarter | EROC | TMO |
|---|---|---|
| Q4 2020 | none listed holders, n.a. | 33 holders, $39.2bn |
| Q1 2021 | none listed holders, n.a. | 35 holders, $36.5bn |
| Q2 2021 | none listed holders, n.a. | 33 holders, $38.3bn |
| Q3 2021 | none listed holders, n.a. | 32 holders, $42.6bn |
| Q4 2021 | none listed holders, n.a. | 38 holders, $50.1bn |
| Q1 2022 | none listed holders, n.a. | 32 holders, $43.2bn |
| Q2 2022 | none listed holders, n.a. | 33 holders, $38.9bn |
| Q3 2022 | none listed holders, n.a. | 26 holders, $34.3bn |
| Q4 2022 | none listed holders, n.a. | 29 holders, $37.0bn |
| Q1 2023 | none listed holders, n.a. | 35 holders, $37.1bn |
| Q2 2023 | none listed holders, n.a. | 39 holders, $33.5bn |
| Q3 2023 | none listed holders, n.a. | 39 holders, $32.6bn |
| Q4 2023 | none listed holders, n.a. | 41 holders, $32.7bn |
| Q1 2024 | none listed holders, n.a. | 30 holders, $34.1bn |
| Q2 2024 | none listed holders, n.a. | 38 holders, $30.6bn |
| Q3 2024 | none listed holders, n.a. | 30 holders, $33.8bn |
| Q4 2024 | none listed holders, n.a. | 36 holders, $27.6bn |
| Q1 2025 | none listed holders, n.a. | 31 holders, $24.2bn |
| Q2 2025 | none listed holders, n.a. | 39 holders, $18.8bn |
| Q3 2025 | none listed holders, n.a. | 32 holders, $21.9bn |
| Q4 2025 | none listed holders, n.a. | 32 holders, $29.9bn |
| Q1 2026 | none listed holders, n.a. | 34 holders, $24.4bn |
| Q2 2026 | 5 holders, $14m | 36 holders, $26.4bn |
| Q3 2026 | none listed holders, n.a. | 35 holders, $40.3bn |
Erock Inc
- Holders
- 0
- Reported value
- $0
- Buyers
- n.a.
- Sellers
- n.a.
No cross-section for this quarter.
Thermo Fisher Scientific Inc
- Holders
- 30
- Reported value
- $34.1bn
- Buyers
- 14
- Sellers
- 18
Breadth -4 among 93 comparable managers.
Who holds both, Q1 2024
Both (0)
No tracked manager lists every one of them.
Only EROC (0)
None.
Only TMO (30)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Baillie Gifford & Co, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Farallon Capital Management LLC, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Moore Capital Management LP, Neuberger Berman Group LLC, Point72 Asset Management LP, Polen Capital Management LLC, Quantbot Technologies LP, Steadfast Capital Management LP, T. Rowe Price Associates Inc, TCI Fund Management Ltd, and 5 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.